Skip to main content
. 2021 Apr 6;14(6):113. doi: 10.3892/mco.2021.2275

Figure 1.

Figure 1

HBV-DNA and ALT levels trend during entecavir therapy. HBV, hepatitis B virus; ALT, alanine transaminase.